Company Overview

For personal use only IHL-216A Concussion Problem Concussion and minor TBI (Traumatic Brain Injury) have major long term effects include cognitive deficits, depression and anxiety. Current recommendations are simply to avoid strenuous activities. Solution IHL-216A aims to improve recovery time by combining CBD and isoflurane to target inflammatory, oxidative and excitative components of the secondary injury mechanism of TBI. Clinical development status Asset IHL-216A TBI/Concussion Incannex Preclinical FDA Pre-IND Phase 1 CT FDA IND Addressable Market FDA Phase 2 US$2.9B 8.3% Global TBI market size in 2019 FDA Phase 3 Lead Assets .....00000 Projected annual growth rate from 2020 to 2027 (6) https://www.grandviewresearch.com/industry-analysis/traumatic-brain-injuries-tbi-assessment-management-devices-market Anticipated Milestones FDA pre-IND Q3 2022 Commencement of Phase 1 CT Investor Presentation 24

View entire presentation